X-13600087-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_015507.4(EGFL6):c.393G>A(p.Thr131=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000579 in 1,208,708 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000055 ( 0 hom. 3 hem. )
Consequence
EGFL6
NM_015507.4 synonymous
NM_015507.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.76
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-13600087-G-A is Benign according to our data. Variant chrX-13600087-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2660025.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-5.76 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGFL6 | NM_015507.4 | c.393G>A | p.Thr131= | synonymous_variant | 4/12 | ENST00000361306.6 | |
EGFL6 | NM_001167890.2 | c.393G>A | p.Thr131= | synonymous_variant | 4/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGFL6 | ENST00000361306.6 | c.393G>A | p.Thr131= | synonymous_variant | 4/12 | 1 | NM_015507.4 | A2 | |
EGFL6 | ENST00000380602.3 | c.393G>A | p.Thr131= | synonymous_variant | 4/12 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111521Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33697
GnomAD3 genomes
AF:
AC:
1
AN:
111521
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33697
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000276 AC: 5AN: 181418Hom.: 0 AF XY: 0.0000303 AC XY: 2AN XY: 65920
GnomAD3 exomes
AF:
AC:
5
AN:
181418
Hom.:
AF XY:
AC XY:
2
AN XY:
65920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000547 AC: 6AN: 1097137Hom.: 0 Cov.: 30 AF XY: 0.00000828 AC XY: 3AN XY: 362531
GnomAD4 exome
AF:
AC:
6
AN:
1097137
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
362531
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111571Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33757
GnomAD4 genome
AF:
AC:
1
AN:
111571
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33757
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | EGFL6: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at